CA2719830F - Chewing gum compositions comprising cannabinoids - Google Patents
Chewing gum compositions comprising cannabinoidsInfo
- Publication number
- CA2719830F CA2719830F CA2719830A CA2719830A CA2719830F CA 2719830 F CA2719830 F CA 2719830F CA 2719830 A CA2719830 A CA 2719830A CA 2719830 A CA2719830 A CA 2719830A CA 2719830 F CA2719830 F CA 2719830F
- Authority
- CA
- Canada
- Prior art keywords
- chewing gum
- cannabinoids
- gum compositions
- chewing
- gum composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Mechanical Engineering (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Composite Materials (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
Abstract
The present invention relates to a chewing gum composition comprising 0.01 to 15 % by weight a cannabinoid or a derivative thereof, based on the total weight of the chewing gum composition, and to chewing gums and blistering packages com-prising said chewing gums.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3945108P | 2008-03-26 | 2008-03-26 | |
US61/039,451 | 2008-03-26 | ||
PCT/NL2009/050149 WO2009120080A1 (en) | 2008-03-26 | 2009-03-26 | Chewing gum compositions comprising cannabinoids |
Publications (3)
Publication Number | Publication Date |
---|---|
CA2719830A1 CA2719830A1 (en) | 2009-10-01 |
CA2719830F true CA2719830F (en) | 2009-10-01 |
CA2719830C CA2719830C (en) | 2017-08-08 |
Family
ID=40793287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2719830A Expired - Fee Related CA2719830C (en) | 2008-03-26 | 2009-03-26 | Chewing gum compositions comprising cannabinoids |
Country Status (15)
Country | Link |
---|---|
US (2) | US9023322B2 (en) |
EP (1) | EP2280687B1 (en) |
BR (1) | BRPI0910094B1 (en) |
CA (1) | CA2719830C (en) |
DK (1) | DK2280687T3 (en) |
ES (1) | ES2727648T3 (en) |
HR (1) | HRP20190944T1 (en) |
HU (1) | HUE044439T2 (en) |
LT (1) | LT2280687T (en) |
MX (1) | MX2010010607A (en) |
PL (1) | PL2280687T3 (en) |
PT (1) | PT2280687T (en) |
SI (1) | SI2280687T1 (en) |
TR (1) | TR201907776T4 (en) |
WO (1) | WO2009120080A1 (en) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT2280687T (en) | 2008-03-26 | 2019-08-26 | Stichting Sanammad | Chewing gum compositions comprising cannabinoids |
GB2471523A (en) | 2009-07-03 | 2011-01-05 | Gw Pharma Ltd | Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy |
TWI583374B (en) | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy |
GB2514054A (en) | 2011-09-29 | 2014-11-12 | Gw Pharma Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
WO2013147965A1 (en) * | 2012-03-28 | 2013-10-03 | Freeman Keith Gerald | Medical compositions, methods of making and using those compositions, and kits including those compositions |
US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
US9744128B2 (en) | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
GB2527599A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
WO2016029215A1 (en) * | 2014-08-22 | 2016-02-25 | Medipath, Inc. | Compositions and methods for cannabinoid coatings for use in drug delivery |
GB2531278A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
US20160220593A1 (en) * | 2015-02-02 | 2016-08-04 | Axim Biotechnologies, Inc. | Cannabinoid and sugar alcohol complex, methods to make and use |
GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
GB2541191A (en) | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
CA3000862C (en) | 2015-10-07 | 2023-03-14 | Medcan Pharma A/S | Medical chewing gum comprising cannabinoid |
GB2548873B (en) | 2016-03-31 | 2020-12-02 | Gw Res Ltd | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome |
US20170304150A1 (en) * | 2016-04-19 | 2017-10-26 | Ascent Pharmaceuticals, Inc. | Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage forms |
WO2017189375A1 (en) * | 2016-04-27 | 2017-11-02 | Axim Biotechnologies, Inc. | Chewing gum composition comprising cannabinoids and nicotine |
US9901607B2 (en) | 2016-04-28 | 2018-02-27 | Mark J. Silen | Smokeless cannabis composition and method of manufacture |
US20200268652A1 (en) * | 2016-05-15 | 2020-08-27 | Betty Hess | Cannabis infused bubble gum for sub-lingual delivery of cannabinoids |
US10653639B2 (en) | 2016-05-16 | 2020-05-19 | Cv Sciences, Inc. | Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
EP3463287A1 (en) | 2016-05-27 | 2019-04-10 | MedCan Pharma A/S | Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin |
US10765658B2 (en) * | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
EP3474844B1 (en) | 2016-06-28 | 2022-07-27 | Trichomeshell Ltd. | A dosage form for vaporization and smoking |
GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
US9833408B1 (en) | 2016-07-28 | 2017-12-05 | Allen Greenspoon | Orally administrable formulation |
GB2553139A (en) | 2016-08-25 | 2018-02-28 | Gw Res Ltd | Use of cannabinoids in the treatment of multiple myeloma |
US10278951B1 (en) | 2016-09-29 | 2019-05-07 | Jon Newland | Method of treating opiate dependency using tetrahydrocannabinol extracts |
EP3528804B1 (en) * | 2016-10-20 | 2023-07-26 | APIRX Pharmaceutical USA, LLC | Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists |
EP3488220A4 (en) * | 2016-11-29 | 2020-03-04 | Axim Biotechnologies, Inc. | Chewing gum composition comprising cannabinoids and gabapentin |
GB2557921A (en) | 2016-12-16 | 2018-07-04 | Gw Res Ltd | Use of cannabinoids in the treatment of angelman syndrome |
GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
US20190224117A1 (en) * | 2017-06-14 | 2019-07-25 | Yury Leon Shmerlis | Cannabis Extract Chewing Gum |
EP3641726A1 (en) | 2017-06-23 | 2020-04-29 | MedCan Pharma A/S | Cannabinoid pouch |
US10272051B2 (en) * | 2017-08-28 | 2019-04-30 | Axim Biotechnologies, Inc. | Method to treat atopic dermatitis |
GB2569961B (en) | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
GB201806953D0 (en) | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
WO2020051055A2 (en) * | 2018-09-04 | 2020-03-12 | Babak Ghalili | Cannabinoid and menthol gum and lozenge compositions and methods |
WO2020051054A1 (en) * | 2018-09-04 | 2020-03-12 | Babak Ghalili | Cannabinoid and anesthetic gum and lozenge compositions and methods |
US11376227B2 (en) | 2018-09-04 | 2022-07-05 | Babak Ghalili | Cannabinoid and menthol gum and lozenge compositions and methods |
EP3914226A1 (en) | 2019-01-25 | 2021-12-01 | NordicCan A/S | Cannabinoid chewing gum with improved release of cannabinoids |
MX2021008935A (en) | 2019-01-25 | 2021-08-24 | Nordiccan As | Cannabinoid chewing gum with sugar alcohols. |
US11406593B2 (en) | 2019-01-25 | 2022-08-09 | Nordiccan A/S | Cannabinoid chewing gum with high intensity sweeteners |
US11166910B2 (en) | 2019-01-25 | 2021-11-09 | Nordiccan A/S | Cannabinoid chewing gum with sugar alcohols |
US11154496B2 (en) | 2019-01-25 | 2021-10-26 | Nordiccan A/S | Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
US11191720B2 (en) | 2019-01-25 | 2021-12-07 | Nordiccan A/S | Chewing gum with improved delivery of cannabinoids |
US11013685B2 (en) | 2019-01-25 | 2021-05-25 | Nordiccan A/S | Cannabinoid chewing gum with improved release of cannabinoids |
WO2020151789A1 (en) | 2019-01-25 | 2020-07-30 | Medcan Pharma A/S | Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
DK3876742T3 (en) * | 2019-01-25 | 2023-05-01 | Nordiccan As | CANNABINOID CHEWING GUM WITH HIGH INTENSIVE SWEETENERS |
WO2020151793A1 (en) | 2019-01-25 | 2020-07-30 | Medcan Pharma A/S | Chewing gum with improved delivery of cannabinoids |
EP3930696A1 (en) | 2019-03-01 | 2022-01-05 | NordicCan A/S | Tableted chewing gum with enhanced delivery of cannabinoids |
US10933017B2 (en) | 2019-03-01 | 2021-03-02 | Nordiccan A/S | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
EP3876744B1 (en) * | 2019-03-01 | 2023-12-06 | NordicCan A/S | Tableted cannabinoid chewing gum with layered structure |
US11471405B2 (en) | 2019-03-01 | 2022-10-18 | Nordiccan A/S | Tableted chewing gum with enhanced delivery of cannabinoids |
AU2019432305B2 (en) | 2019-03-01 | 2023-03-02 | Nordiccan A/S | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
US10799450B2 (en) | 2019-03-01 | 2020-10-13 | Medcan Pharma A/S | Tableted cannabinoid chewing gum with layered structure |
EP3930695A1 (en) | 2019-03-01 | 2022-01-05 | NordicCan A/S | Tableted cannabinoid chewing gum with improved release |
US11253473B2 (en) | 2019-03-01 | 2022-02-22 | Nordiccan A/S | Method of producing tableted cannabinoid chewing gum |
US20200276118A1 (en) * | 2019-03-01 | 2020-09-03 | Medcan Pharma A/S | Tableted cannabinoid chewing gum with improved release |
MX2022003189A (en) | 2019-09-16 | 2022-06-08 | Vapor Cartridge Tech Llc | Drug delivery system with stackable substrates. |
WO2021078999A1 (en) | 2019-10-25 | 2021-04-29 | Newmark Biotech, Llc | Chewing gum or lozenge composition comprising cbd |
GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
WO2021177942A1 (en) * | 2020-03-03 | 2021-09-10 | Babak Ghalili | Cannabinoid and menthol gum and lozenge compositions and methods |
US11160757B1 (en) | 2020-10-12 | 2021-11-02 | GW Research Limited | pH dependent release coated microparticle cannabinoid formulations |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187320A (en) * | 1978-05-01 | 1980-02-05 | Warner-Lambert Company | Process for preparing chewing gum base using solid elastomer |
DK161428C (en) | 1985-05-10 | 1991-12-16 | Fertin Lab As | SOLID, ORAL CARIAL EFFECTS |
FR2611501B1 (en) * | 1987-03-04 | 1991-12-06 | Corbiere Jerome | NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ROUTE BASED ON LYSINE ACETYLSALIELYLATE AND PROCESS FOR OBTAINING SAME |
DK365389D0 (en) * | 1989-07-24 | 1989-07-24 | Fertin Lab As | ANTIFUNGAL CHEMICAL GUM PREPARATION |
AU9022098A (en) * | 1997-08-20 | 1999-03-08 | Fuisz Technologies Ltd. | Process for improving flow and compression of tableting compositions |
WO2001089476A1 (en) | 2000-05-19 | 2001-11-29 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
US20040028772A1 (en) * | 2000-08-14 | 2004-02-12 | Carsten Andersen | Method for preparation of chewing gum with customer acceptable taste |
GB2377633A (en) | 2001-05-11 | 2003-01-22 | Gw Pharmaceuticals Ltd | Pharmaceutical compositions comprising the cannabinoids THC and CBD |
GB2381194A (en) | 2001-09-07 | 2003-04-30 | Gw Pharmaceuticals Ltd | Pharmaceutical formulations |
US20020160043A1 (en) * | 2001-02-27 | 2002-10-31 | Dennis Coleman | Compositions and method of manufacture for oral dissolvable dosage forms |
FI20020333A0 (en) * | 2002-02-20 | 2002-02-20 | Tomi Jaervinen | Novel Complexes of Methylated Cyclodextrin |
EP1539069A4 (en) | 2002-05-31 | 2007-11-14 | Univ Mississippi | Transmucosal delivery of cannabinoids |
US7004174B2 (en) | 2002-05-31 | 2006-02-28 | Neothermia Corporation | Electrosurgery with infiltration anesthesia |
EA008858B1 (en) * | 2002-07-02 | 2007-08-31 | Гумлинк А/С | Compressed chewing gum |
US6986907B2 (en) | 2003-07-28 | 2006-01-17 | Wm. Wrigley Jr. Company | Chewing gum base and chewing gum compositions |
GB0320854D0 (en) | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
GB2414933B (en) | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
GB0416861D0 (en) * | 2004-07-29 | 2004-09-01 | Quadrant Drug Delivery Ltd | Composition |
CA2578258C (en) * | 2004-08-25 | 2012-11-13 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
GB2432312A (en) | 2005-11-01 | 2007-05-23 | Gw Pharma Ltd | Pharmaceutical compositions for the treatment of pain |
CA2657932A1 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Stable lozenge compositions providing rapid release of nicotine |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
WO2008033024A2 (en) * | 2006-09-15 | 2008-03-20 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
WO2008098195A2 (en) | 2007-02-09 | 2008-08-14 | Todd Maibach | Film comprising nitroglycerin |
LT2280687T (en) | 2008-03-26 | 2019-08-26 | Stichting Sanammad | Chewing gum compositions comprising cannabinoids |
-
2009
- 2009-03-26 LT LTEP09725784.4T patent/LT2280687T/en unknown
- 2009-03-26 TR TR2019/07776T patent/TR201907776T4/en unknown
- 2009-03-26 CA CA2719830A patent/CA2719830C/en not_active Expired - Fee Related
- 2009-03-26 BR BRPI0910094-6A patent/BRPI0910094B1/en not_active IP Right Cessation
- 2009-03-26 WO PCT/NL2009/050149 patent/WO2009120080A1/en active Application Filing
- 2009-03-26 MX MX2010010607A patent/MX2010010607A/en active IP Right Grant
- 2009-03-26 EP EP09725784.4A patent/EP2280687B1/en not_active Revoked
- 2009-03-26 HU HUE09725784 patent/HUE044439T2/en unknown
- 2009-03-26 US US12/934,633 patent/US9023322B2/en active Active
- 2009-03-26 PL PL09725784T patent/PL2280687T3/en unknown
- 2009-03-26 ES ES09725784T patent/ES2727648T3/en active Active
- 2009-03-26 PT PT09725784T patent/PT2280687T/en unknown
- 2009-03-26 DK DK09725784.4T patent/DK2280687T3/en active
- 2009-03-26 SI SI200931971T patent/SI2280687T1/en unknown
-
2015
- 2015-04-10 US US14/684,109 patent/US9433601B2/en active Active
-
2019
- 2019-05-22 HR HRP20190944TT patent/HRP20190944T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0910094B1 (en) | 2021-08-10 |
US20150209322A1 (en) | 2015-07-30 |
CA2719830A1 (en) | 2009-10-01 |
US9023322B2 (en) | 2015-05-05 |
PL2280687T3 (en) | 2019-10-31 |
EP2280687B1 (en) | 2019-02-27 |
PT2280687T (en) | 2019-06-04 |
HRP20190944T1 (en) | 2019-09-20 |
DK2280687T3 (en) | 2019-05-27 |
BRPI0910094A2 (en) | 2015-12-15 |
ES2727648T3 (en) | 2019-10-17 |
SI2280687T1 (en) | 2019-09-30 |
US9433601B2 (en) | 2016-09-06 |
HUE044439T2 (en) | 2019-10-28 |
LT2280687T (en) | 2019-08-26 |
MX2010010607A (en) | 2011-03-29 |
US20110097283A1 (en) | 2011-04-28 |
EP2280687A1 (en) | 2011-02-09 |
CA2719830C (en) | 2017-08-08 |
TR201907776T4 (en) | 2019-06-21 |
WO2009120080A1 (en) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2719830F (en) | Chewing gum compositions comprising cannabinoids | |
MX2010010508A (en) | Sebum absorption compositions. | |
TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
MX2011013794A (en) | Oral care compositions. | |
MX342107B (en) | Coating compositions, confectionery and chewing gum compositions and methods. | |
BRPI0911847B8 (en) | nicotine gum compositions | |
TW200621313A (en) | Pharmaceutical compositions | |
BR112013026802A2 (en) | improved peroxide stability in oral treatment compositions | |
MY158777A (en) | Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof | |
WO2008085450A3 (en) | Free-flowing filler composition and rubber composition containing same | |
MX2009013021A (en) | Center-fill gum compositions incorporating triacetin. | |
BR112012032882A2 (en) | increased release of lopophilic ingredients from hydrocolloid chewing gum | |
MX2009008229A (en) | Degradable chewing gum. | |
MX2009007389A (en) | Oral care compositions comprising a hippophae extract. | |
WO2010122332A3 (en) | Xanthan gum and swellable particulate containing composition and uses thereof | |
ATE523186T1 (en) | DENTAL COMPOSITIONS WITH WATER CATCHER | |
BRPI0408895A (en) | Cladribine formulations for improved oral and transmucosal administration | |
WO2007012080A3 (en) | Oral care composition | |
DE602008003117D1 (en) | SOFT PROPYLENE POLYMER COMPOSITIONS | |
DK1971216T3 (en) | CHEWING GUM CONTAINING STYRENE-DIEN BLOCK COPYLYMERS | |
ATE533814T1 (en) | MODIFIED OLEFIN POLYMERS | |
MY149433A (en) | Nutritional compositions containing punicalagins | |
WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions | |
MX2009008249A (en) | Pharmaceutical composition comprising a campothecin derivative. | |
MX2011009364A (en) | Chewing gum compositions providing flavor release profiles. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20140228 |
|
MKLA | Lapsed |
Effective date: 20210326 |